News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
COLUMN GROUP II, LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/11/2022 |
SC 13G/A
| COLUMN GROUP II, LP reports a 9.3% stake in ORIC PHARMACEUTICALS, INC. |
| 09/20/2021 |
SC 13D/A
| COLUMN GROUP II, LP reports a 10.7% stake in RAPT THERAPEUTICS, INC. |
| 09/07/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/30/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/12/2021 |
SC 13G
| COLUMN GROUP II, LP reports a 13.1% stake in ORIC PHARMACEUTICALS, INC. |
| 02/12/2021 |
SC 13G/A
| COLUMN GROUP II, LP reports a 0% stake in Gritstone Oncology, Inc. |
| 11/04/2020 |
SC 13G/A
| COLUMN GROUP II, LP reports a 0% stake in Arcus Biosciences, Inc. |
| 10/01/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/26/2020 |
SC 13D/A
| COLUMN GROUP II, LP reports a 25.6% stake in RAPT THERAPEUTICS, INC. |
| 02/14/2020 |
SC 13D/A
| COLUMN GROUP II, LP reports a 27.9% stake in RAPT THERAPEUTICS, INC. |
| 11/08/2019 |
SC 13D
| COLUMN GROUP II, LP reports a 31.8% stake in RAPT THERAPEUTICS, INC. |
| 02/13/2019 |
SC 13G
| COLUMN GROUP II, LP reports a 10.7% stake in Gritstone Oncology, Inc. |
| 02/13/2019 |
SC 13G
| COLUMN GROUP II, LP reports a 8% stake in Arcus Biosciences, Inc. |
|
|